4//SEC Filing
Schneyer Mark C. 4
Accession 0001415889-25-013741
CIK 0001070494other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 8:50 PM ET
Size
5.1 KB
Accession
0001415889-25-013741
Insider Transaction Report
Form 4
Schneyer Mark C.
EVP, CHIEF FINANCIAL OFFICER
Transactions
- Sale
Common Stock
2025-05-16$25.00/sh−2,000$50,000→ 62,130 total
Footnotes (2)
- [F1]The sales reported on this Form 4 were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 30, 2024.
- [F2]Includes 1,357 shares of the Issuer's common stock acquired by the Reporting Person on May 15, 2025 pursuant to an employee stock purchase plan.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeother
Related Parties
1- filerCIK 0001899977
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 8:50 PM ET
- Size
- 5.1 KB